arrow
S

Stefan Hohaus

Gemelli Foundation
H指数:46
被引数:7,037

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Independent validation of the International Metabolic Prognostic Index (CAR-IMPI) in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T

国际代谢预后指数(CAR-IMPI)在CAR-T治疗的高侵袭性弥漫大B细胞淋巴瘤患者中的独立验证

2026-09-170
OAAI
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network

更正:Siltuximab 作为特发性多中心性 Castleman 病的一线疗法:一项基于意大利区域网络 SiMuLa 研究的回顾性分析

2026-03-110
OAAI
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network

西妥昔单抗作为特发性多中心性卡斯特曼病的初始治疗方案:一项基于意大利区域网络SiMuLa研究的回顾性分析

2026-02-160
OAAI
Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc Analysis of Italian Real-World Data from the PRO-MIND Study

与健康相关的生活质量及症状负担:在接受Tafasitamab和Lenalidomide治疗前的弥漫性大B细胞淋巴瘤患者:PRO-MIND研究意大利真实世界数据的临时分析

2025-12-150
OAAI
Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great Mimic

成人发病的家族性2型噬血细胞性淋巴组织细胞增多症在SARS-CoV-2疫苗接种后出现,并伴有不典型的神经系统首发症状:伪装大师

2025-11-270
OAAI
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study

利妥昔单抗、 bendamustine 和 cytarabine,随后使用 venetoclax 治疗高风险套细胞淋巴瘤老年患者(FIL_V-RBAC):一项多中心、单臂、Ⅱ期研究

2025-09-170
PRE
Routine Prophylaxis with Levetiracetam offers no benefit in CD19 CAR-T for LBCL: a Multicenter Propensity-matched Study

常规使用左乙拉西坦进行预防对LBCL的CD19 CAR-T治疗无益:一项多中心倾向性匹配研究

2025-08-110
OAAI
First-line treatment of Waldenstrom's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies
2024-11-190
OAAI
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Ctdna

利用ctDNA对经典霍奇金淋巴瘤进行的全面遗传学研究

BLOOD
IF23.1
2024-11-050
PRE
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial
2024-07-231
OAAI
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study
2024-03-274
OAAI
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy?
2023-10-026
OAAI
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
2023-08-015
OAAI